Abdelfattah N, Kumar P, Wang C, Leu JS, Flynn WF, Gao R et al (2022) Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat Commun 13:767. https://doi.org/10.1038/s41467-022-28372-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abdullah KG, Bird CE, Buehler JD, Gattie LC, Savani MR, Sternisha AC et al (2022) Establishment of patient-derived organoid models of lower-grade glioma. Neuro Oncol 24:612–623. https://doi.org/10.1093/neuonc/noab273

Article  CAS  PubMed  Google Scholar 

Al-Ali R, Bauer K, Park JW, Al Abdulla R, Fermi V, von Deimling A et al (2019) Single-nucleus chromatin accessibility reveals intratumoral epigenetic heterogeneity in IDH1 mutant gliomas. Acta Neuropathol Commun 7:201. https://doi.org/10.1186/s40478-019-0851-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Al-Dalahmah O, Argenziano MG, Kannan A, Mahajan A, Furnari J, Paryani F et al (2023) Re-convolving the compositional landscape of primary and recurrent glioblastoma reveals prognostic and targetable tissue states. Nat Commun 14:2586. https://doi.org/10.1038/s41467-023-38186-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aldape K, Brindle KM, Chesler L, Chopra R, Gajjar A, Gilbert MR et al (2019) Challenges to curing primary brain tumours. Nat Rev Clin Oncol 16:509–520. https://doi.org/10.1038/s41571-019-0177-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV et al (2013) Signatures of mutational processes in human cancer. Nature 500:415–421. https://doi.org/10.1038/nature12477

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alphones S, Chatterjee U, Singh A, Das A, Zameer L, Achari R et al (2021) Immunohistochemical screening for mismatch repair protein deficiency in paediatric high-grade gliomas—institutional experience and review of literature. Childs Nerv Syst 37:2521–2530. https://doi.org/10.1007/s00381-021-05229-1

Article  PubMed  Google Scholar 

Andrade JR, Gallagher AD, Maharaj J, McClelland SE (2023) Disentangling the roles of aneuploidy, chromosomal instability and tumour heterogeneity in developing resistance to cancer therapies. Chromosome Res 31:28. https://doi.org/10.1007/s10577-023-09737-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andronesi OC, Rapalino O, Gerstner E, Chi A, Batchelor TT, Cahill DP et al (2013) Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate. J Clin Invest 123:3659–3663. https://doi.org/10.1172/JCI67229

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aoki K, Nakamura H, Suzuki H, Matsuo K, Kataoka K, Shimamura T et al (2018) Prognostic relevance of genetic alterations in diffuse lower-grade gliomas. Neuro Oncol 20:66–77. https://doi.org/10.1093/neuonc/nox132

Article  CAS  PubMed  Google Scholar 

Arita H, Matsushita Y, Machida R, Yamasaki K, Hata N, Ohno M et al (2020) TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations. Acta Neuropathol Commun 8:201. https://doi.org/10.1186/s40478-020-01078-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Babikir H, Wang L, Shamardani K, Catalan F, Sudhir S, Aghi MK et al (2021) ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma. Genome Biol 22:311. https://doi.org/10.1186/s13059-021-02535-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bakhoum SF, Danilova OV, Kaur P, Levy NB, Compton DA (2011) Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma. Clin Cancer Res 17:7704–7711. https://doi.org/10.1158/1078-0432.CCR-11-2049

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bakhoum SF, Thompson SL, Manning AL, Compton DA (2009) Genome stability is ensured by temporal control of kinetochore-microtubule dynamics. Nat Cell Biol 11:27–35. https://doi.org/10.1038/ncb1809

Article  CAS  PubMed  Google Scholar 

Ballhausen A, Przybilla MJ, Jendrusch M, Haupt S, Pfaffendorf E, Seidler F et al (2020) The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution. Nat Commun 11:4740. https://doi.org/10.1038/s41467-020-18514-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A (2008) Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 116:597–602. https://doi.org/10.1007/s00401-008-0455-2

Article  CAS  PubMed  Google Scholar 

Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E et al (2019) Longitudinal molecular trajectories of diffuse glioma in adults. Nature 576:112–120. https://doi.org/10.1038/s41586-019-1775-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Behan FM, Iorio F, Picco G, Goncalves E, Beaver CM, Migliardi G et al (2019) Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. Nature 568:511–516. https://doi.org/10.1038/s41586-019-1103-9

Article  CAS  PubMed  Google Scholar 

Bhatia A, Kumar Y (2013) Cancer cell micronucleus: an update on clinical and diagnostic applications. APMIS 121:569–581. https://doi.org/10.1111/apm.12033

Article  PubMed  Google Scholar 

Bhatia A, Kumar Y (2014) Relevance of microscopic indicators of chromosomal instability in routine reporting of malignancies. Diagn Cytopathol 42:181–188. https://doi.org/10.1002/dc.23012

Article  PubMed  Google Scholar 

Blanco-Carmona E, Narayanan A, Hernandez I, Nieto JC, Elosua-Bayes M, Sun X et al (2023) Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas. Cell Rep Med 4:101249. https://doi.org/10.1016/j.xcrm.2023.101249

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bleeker FE, Lamba S, Leenstra S, Troost D, Hulsebos T, Vandertop WP et al (2009) IDH1 mutations at residue p. R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat 30:7–11. https://doi.org/10.1002/humu.20937

Article  CAS  PubMed  Google Scholar 

Bomsztyk K, Mar D, Denisenko O, Powell S, Vishnoi M, Delegard J et al (2024) Analysis of gliomas DNA methylation: assessment of pre-analytical variables. bioRxiv. https://doi.org/10.1101/2024.03.26.586350

Article  PubMed  PubMed Central  Google Scholar 

Bouffet E, Larouche V, Campbell BB, Merico D, de Borja R, Aronson M et al (2016) Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency. J Clin Oncol 34:2206–2211. https://doi.org/10.1200/JCO.2016.66.6552

Article  CAS  PubMed  Google Scholar 

Brandes AA, Franceschi E, Paccapelo A, Tallini G, De Biase D, Ghimenton C et al (2017) Role of MGMT methylation status at time of diagnosis and recurrence for patients with glioblastoma: clinical implications. Oncologist 22:432–437. https://doi.org/10.1634/theoncologist.2016-0254

Article  CAS  PubMed  PubMed Central